Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
aflibercept, air, appeal, asleep, Athlone, Australia, Century, cleanup, COBRA, dealing, deLong, divergent, Donald, Dr, DSCSA, duyk, EA, Eastern, entail, feedback, floor, forward, Ganfort, geoffrey, greatly, Guaranty, ineffective, injectable, interior, Jill, Lin, Malta, Mitchell, motion, nocturnal, Nonqualified, parent, petechaie, petechiae, pilot, pipeline, placebo, pre, presidential, principle, qualification, reconsideration, renew, resign, saleable, shell, spent, stricter, strictly, Sturdivant, successor, therewith, Trump, twelve, unfold, unlimited, verification, verticillata, water, withholding
Removed:
accounted, accreted, ACP, adjunct, adjusting, black, box, Brian, central, chosen, comprising, dry, embedded, extinguishment, Haarlem, immaterial, issuable, Levy, moderate, Osage, par, phd, pie, reclassification, reclassified, reclassifying, redemption, reserved, retroactively, revealed, salaried, scheduled, Separation, served, Sofinnova, split, static, statistical, thereon, tolerated, TPG, triple, troubled, unaffiliated, unequivocally, van, VII
Filing tables
Filing exhibits
- 10-K Annual report
- 4.1.1 Exhibit 4.1.1
- 10.19 Exhibit 10.19
- 10.20 Exhibit 10.20
- 10.21 Exhibit 10.21
- 10.16.1 Exhibit 10.16.1
- 10.17.1 Exhibit 10.17.1
- 10.18.1 Exhibit 10.18.1
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 31.1 Exhibit 31.1
- 31.2 Exhibit 31.2
- 32.1 Exhibit 32.1
- 32.2 Exhibit 32.2
- Download Excel data file
- View Excel data file
Related press release
AERI similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-213643 and No. 333-199821) and Form S-8 (No. 333-192030) of Aerie Pharmaceuticals, Inc. of our report dated March 9, 2017 relating to the consolidated financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Florham Park, NJ
March 9, 2017